Plan sponsors should get ahead of this trend by proactively evaluating how DTC models could impact their drug spend and explore options that maintain prescription affordability and access
Tirzepatide: MEDVi Launches Physician-Led Program to Help Patien MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program designed to help patients navigate the decision between semaglutide and tirzepatide, two GLP-1 medications at the center of the weight loss conversation in 2026 Image: Disclosure: This announcement is for informational purposes only and does not constitute medical advice
Corporate risk aversion: As a subsidiary of a publicly traded company, PlushCare likely views compounding as carrying regulatory and legal risks particularly after Novo Nordisk's lawsuits against telehealth platforms that marketed compounded semaglutide
1.7 mg solution for injection, prefilled pens
Astrocytopathies with aberrant pathological astrocytes Aberrant astrocytes that may act as instigators and propagators of neuropathology have been described in several diseases
Its, on occasion, blended with glutathione for a better whitening effect
